Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.
Press releases published on July 16, 2025
Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital
GlobeNewswire
·
July 16, 2025
CHICAGO, July 16, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch today with $50 million of committed capital. Founded to address urgent unmet needs in rare and life-threatening …
Obstructive Sleep Apnea Clinical Trial Pipeline Expands as 12+ Companies Driving Innovation in OSA Therapeutics | DelveInsight
GlobeNewswire
·
July 16, 2025
New York, USA, July 16, 2025 (GLOBE NEWSWIRE) -- Obstructive Sleep Apnea Clinical Trial Pipeline Expands as 12+ Companies Driving Innovation in OSA Therapeutics | DelveInsight The obstructive sleep apnea (OSA) market is being propelled by the rapid …
Constant Therapy Announces Collaboration with Burke Rehabilitation to Offer NY's First AI-Driven Post-Acute Outpatient Speech Therapy
GlobeNewswire
·
July 16, 2025
LEXINGTON, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Constant Therapy today announced a first-in-state collaboration with New York-based Burke Rehabilitation to launch an AI-powered post-acute speech therapy program for patients with stroke, brain injuries, …
Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch
GlobeNewswire
·
July 16, 2025
Advanced algorithms aim to reduce trial planning timelines, accelerating time-to-market for new therapies Initiative to support Tevogen Bio’s ExacTcell™ pipeline with a goal of enhancing commercial viability and shareholder value WARREN, N.J., July 16, …
eMI Aesthetics Announces Launch of AI-Powered Aesthetic Simulation Platform for Cosmetic Treatment Visualization
GlobeNewswire
·
July 16, 2025
Miami, FL, July 16, 2025 (GLOBE NEWSWIRE) -- eMI Aesthetics, a leader in AI-driven cosmetic imaging, today announced the launch of its AI-powered aesthetic simulation platform for cosmetic treatment visualization. With over 100,000 users, eMI Aesthetics' …
Aesthetic Business Strategist Dr. Kalpana Sundar to Host Transformational Profit Accelerator Bootcamp for Medspa Owners in Albuquerque – August 7–10, 2025
GlobeNewswire
·
July 16, 2025
ALBUQUERQUE, New Mexico, July 16, 2025 (GLOBE NEWSWIRE) -- As the medical aesthetics industry continues to experience exponential growth, many medspa owners and aesthetic providers find themselves overwhelmed — juggling clients, marketing, operations, and …
A Statement from the Global Virus Network (GVN) on the Rapidly Escalating Measles Crisis in the U.S. and Worldwide
GlobeNewswire
·
July 16, 2025
TAMPA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries, is sounding the alarm over a sharp resurgence of …
Dallas Business Journal Recognizes U.S. Oral Surgery Management for Continued Growth
GlobeNewswire
·
July 16, 2025
IRVING, Texas, July 16, 2025 (GLOBE NEWSWIRE) -- For the second year in a row, the Dallas Business Journal has named Irving’s U.S. Oral Surgery Management (USOSM) to this year’s Fast 50 – a list of the 50 fastest growing companies in the Dallas-Fort Worth …
Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions
GlobeNewswire
·
July 16, 2025
WARRINGTON, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is excited to announce it has entered into a $60 million securities purchase agreement led by Build and Build Corp, with the …
OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain
GlobeNewswire
·
July 16, 2025
After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly effective treatment. Urcosimod (0.05%) …
Intuitive demonstrates telesurgery capabilities
GlobeNewswire
·
July 16, 2025
SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has today demonstrated its telesurgery capabilities by remotely connecting two …
Gain Therapeutics Announces Pricing of $7.0 Million Public Offering
GlobeNewswire
·
July 16, 2025
BETHESDA, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Lattimore Physical Therapy & Sports Rehabilitation Network Rolls Out Athelas Air to 35 Locations
GlobeNewswire
·
July 16, 2025
MOUNTAIN VIEW, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Athelas, healthcare technology company powered by Commure, today announced the successful deployment of its unified EHR platform, Athelas Air, at Lattimore Physical Therapy …
Ensemble Announces Strategic Revenue Cycle Partnership with Methodist Le Bonheur Healthcare
GlobeNewswire
·
July 16, 2025
CINCINNATI, Ohio, July 16, 2025 (GLOBE NEWSWIRE) -- Ensemble, the nation’s leading revenue cycle managed services partner for healthcare organizations, announced today that Methodist Le Bonheur Healthcare (MLH) has selected it as its strategic revenue …
Following Psychedelic Science 2025 Success, MAPS Publishes First of Hundreds of Conference Session Videos
GlobeNewswire
·
July 16, 2025
Enhanced Virtual Trip platform goes live with improved user experience and first selection of PS2025 session videos Conference drew 8,000+ attendees, more than $1 million donated, and 1,100+ recurring donors joined the new membership program MAPS …
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
GlobeNewswire
·
July 16, 2025
Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today commented on recent stock price …
DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC
GlobeNewswire
·
July 16, 2025
BROSSARD, Quebec, July 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the early detection of retinal and systemic diseases, is …
DIAGNOS dépose une pré-soumission auprès de la FDA pour son système CARA : Entrée stratégique sur le marché américain de l'optométrie avec le soutien d'ORA LLC
GlobeNewswire
·
July 16, 2025
BROSSARD, Québec, 16 juill. 2025 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), un leader canadien de l'intelligence artificielle (IA) pour la détection précoce des maladies …
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
GlobeNewswire
·
July 16, 2025
LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRush™, a next-generation nootropic designed to support sustained cognitive …
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
GlobeNewswire
·
July 16, 2025
SARASOTA, FL, July 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced completion of dosing in a U …